Compare MCK & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MCK | SYK |
|---|---|---|
| Founded | 1833 | 1941 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 106.8B | 127.0B |
| IPO Year | 1995 | 1994 |
| Metric | MCK | SYK |
|---|---|---|
| Price | $867.37 | $339.51 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 13 |
| Target Price | ★ $951.38 | $418.08 |
| AVG Volume (30 Days) | 662.1K | ★ 2.0M |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | 0.38% | ★ 1.04% |
| EPS Growth | ★ 14.87 | 8.25 |
| EPS | ★ 24.73 | 8.40 |
| Revenue | ★ $112,084,000,000.00 | $25,116,000,000.00 |
| Revenue This Year | $14.97 | $9.85 |
| Revenue Next Year | $8.20 | $8.36 |
| P/E Ratio | ★ $35.31 | $40.32 |
| Revenue Growth | 3.11 | ★ 11.16 |
| 52 Week Low | $637.00 | $319.32 |
| 52 Week High | $999.00 | $404.87 |
| Indicator | MCK | SYK |
|---|---|---|
| Relative Strength Index (RSI) | 41.24 | 46.81 |
| Support Level | $796.22 | $328.23 |
| Resistance Level | $883.49 | $375.26 |
| Average True Range (ATR) | 19.67 | 7.54 |
| MACD | -0.48 | 2.14 |
| Stochastic Oscillator | 35.62 | 77.51 |
McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.